Tricor and Encephalopathy - a phase IV clinical study of FDA data

Summary:

Encephalopathy is reported as a side effect among people who take Tricor (fenofibrate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Coumadin, and have Depression.

The phase IV clinical study analyzes which people have Encephalopathy when taking Tricor. It is created by eHealthMe based on reports of 21,730 people who have side effects when taking Tricor from the FDA, and is updated regularly.

What is Tricor?

Tricor has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 22,641 Tricor users. Check the latest studies of Tricor.

What is Encephalopathy?

Encephalopathy (functioning of the brain is affected by some agent or condition) is found to be associated with 1,467 drugs and 1,602 conditions by eHealthMe. Check the latest studies of Encephalopathy.

On Jul, 16, 2026

21,730 people reported to have side effects when taking Tricor.
Among them, 41 people (0.19%) have Encephalopathy.

Among these 41 people:

How long have people been on Tricor when they have Encephalopathy? *

What is the gender of people who have Encephalopathy when taking Tricor? *

female: 20 %
male: 80 %

What is the age of people who have Encephalopathy when taking Tricor? *

What are other drugs people take besides Tricor? *

What are other side effects people have besides Encephalopathy? *

Acute Kidney Failure: 17 people, 41.46%
Pain: 17 people, 41.46%
Fatigue (feeling of tiredness): 14 people, 34.15%
Stress And Anxiety: 13 people, 31.71%
International Normalised Ratio Increased: 13 people, 31.71%
Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 13 people, 31.71%
Anaemia (lack of blood): 13 people, 31.71%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 13 people, 31.71%
High Blood Pressure: 11 people, 26.83%
Pulmonary Oedema (fluid accumulation in the lungs): 11 people, 26.83%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 7 people, 17.07%
Depression: 7 people, 17.07%
High Blood Pressure: 6 people, 14.63%
Diabetes: 6 people, 14.63%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 12.20%
Pain: 5 people, 12.20%
Sleep Disorder: 4 people, 9.76%
Bipolar Disorder (mood disorder): 4 people, 9.76%
Premenstrual Syndrome: 4 people, 9.76%
Heavy Or Prolong Menstrual Bleeding: 4 people, 9.76%

* Approximation only. Some reports may have incomplete information.

Do you take Tricor and have Encephalopathy?

- Check whether Encephalopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tricor:

Tricor (22,641 reports)

Encephalopathy treatments and more:

Encephalopathy (27,832 reports)

Browse all side effects of Tricor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Encephalopathy:

Encephalopathy (1,467 drugs)

Browse all the conditions that are associated with Encephalopathy:

Encephalopathy (1,602 conditions)

Related publications that referenced our studies

Kapoor A, Kumar V, Beniwal S, Dutta S, Goyal S, Kumar HS, "Posterior reversible encephalopathy syndrome in non-Hodgkin's lymphoma: Not necessarily reversible!", Clinical Cancer Investigation Journal, 2015 Mar .
Kapoor A, Kumar V, Beniwal S, Dutta S, Goyal S, Kumar HS, "Posterior reversible encephalopathy syndrome in non-Hodgkin's lymphoma: Not necessarily reversible!", Clinical Cancer Investigation Journal, 2015 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on fenofibrate (the active ingredients of Tricor) and Tricor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.